Literature DB >> 12087146

Decision making with cardiac troponin tests.

Elliott M Antman.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12087146     DOI: 10.1056/NEJMe020049

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  A review of troponins in ischemic heart disease and other conditions.

Authors:  Nedaa Skeik; Deevia Chandrakant Patel
Journal:  Int J Angiol       Date:  2007

Review 2.  Perspective on the clinical application of troponin in heart failure and states of cardiac injury.

Authors:  Almasa Bass; J Herbert Patterson; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2009-04-05       Impact factor: 4.214

3.  A phase I study of T900607 given once every 3 weeks in patients with advanced refractory cancers; National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) IND 130.

Authors:  Karen A Gelmon; Karl Belanger; Denis Soulieres; Carolyn Britten; Stephen Chia; Danielle Charpentier; Kim Chi; Jean Powers; Wendy Walsh; Lesley Seymour
Journal:  Invest New Drugs       Date:  2005-10       Impact factor: 3.850

4.  Predictors of High-Sensitivity Cardiac Troponin T Elevation in Patients with Acute Paroxysmal Supraventricular Tachycardia and Ischemic Heart Disease.

Authors:  Mehdi Sayadnik; Akbar Shafiee; Yaser Jenab; Arash Jalali; Saeed Sadeghian
Journal:  Tex Heart Inst J       Date:  2017-10-01

5.  Autonomic and cellular mechanisms mediating detrimental cardiac effects of status epilepticus.

Authors:  Steven L Bealer; Jason G Little; Cameron S Metcalf; Amy L Brewster; Anne E Anderson
Journal:  Epilepsy Res       Date:  2010-07-21       Impact factor: 3.045

6.  Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.

Authors:  Samo Zver; Vesna Zadnik; Matjaz Bunc; Polona Rogel; Peter Cernelc; Mirta Kozelj
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

7.  Drug-induced cardiotoxicity due to aminophylline treatment: a case report.

Authors:  Ioannis Starakis; Ioannis Starakis; Alexandra Lekkou; Alexandros Blikas; Chrysoula Labropoulou-Karatza
Journal:  Curr Ther Res Clin Exp       Date:  2003-06

Review 8.  Use of high-sensitivity troponin assays predicts mortality in patients with normal conventional troponin assays on admission-insights from a meta-analysis.

Authors:  Saurav Chatterjee; Jiwon Kim; Ali Dahhan; Gaurav Choudhary; Satish Sharma; Wen-Chih Wu
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

9.  Quartiles of peak troponin are associated with long-term risk of death in type 1 and STEMI, but not in type 2 or NSTEMI patients.

Authors:  Manuel A Gonzalez; Christopher P Porterfield; Dana J Eilen; Rana A Marzouq; Hiren R Patel; Amit A Patel; Summiyah Nasir; Heang M Lim; Joseph D Babb; John D Rose; Wayne E Cascio
Journal:  Clin Cardiol       Date:  2009-10       Impact factor: 2.882

10.  Sensitive Cardiac Troponins: Could They Be New Biomarkers in Pediatric Pulmonary Hypertension Due to Congenital Heart Disease?

Authors:  Seyma Kayali; Ilker Ertugrul; Tamer Yoldas; Ozkan Kaya; Senem Ozgür; Utku A Orün; Selmin Karademir
Journal:  Pediatr Cardiol       Date:  2018-01-16       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.